RxSight, Inc.
RXST • NASDAQ
RxSight, Inc. is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Ronald Kurtz, with a market cap of $312.9M.
CEORonald Kurtz
Market Cap$312.9M
Medical - Devices
Healthcare
Employees374.0
Websiterxsight.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for RxSight, Inc.
Date
Wednesday, May 6, 2026 (in 2 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.22
Revenue Estimate
$30.4M
Earnings History
Past 12 earnings reports for RxSight, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 25, 2026 | Q4 2025 | -$0.03Est: -$0.28 | +89.3% | $32.6MEst: $32.6M | +0.0% |  10-K |
| Nov 5, 2025 | Q3 2025 | -$0.04Est: -$0.27 | +85.2% | $30.3MEst: $25.6M | +18.5% | 10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.08Est: -$0.18 | +55.6% | $33.6MEst: $33.6M | +0.1% | 10-Q |
| May 7, 2025 | Q1 2025 | -$0.03Est: -$0.06 | +50.0% | $37.9MEst: $37.9M | +0.0% | 10-Q |
| Feb 25, 2025 | Q4 2024 | $0.03Est: -$0.01 | +400.0% | $40.2MEst: $40.2M | -0.0% | 10-K |
| Nov 7, 2024 | Q3 2024 | $0.00Est: -$0.25 | +100.0% | $35.3MEst: $35.1M | +0.7% | 10-Q |
| Aug 5, 2024 | Q2 2024 | $0.00Est: -$0.22 | +100.0% | $34.9MEst: $32.3M | +8.1% | 10-Q |
| May 6, 2024 | Q1 2024 | -$0.12Est: -$0.27 | +55.6% | $29.5MEst: $27.6M | +7.1% | 10-Q |
| Feb 28, 2024 | Q4 2023 | -$0.13Est: -$0.36 | +63.9% | $28.6MEst: $27.4M | +4.2% | 10-K |
| Nov 9, 2023 | Q3 2023 | -$0.19Est: -$0.43 | +55.8% | $22.2MEst: $20.6M | +8.0% | — |
| Aug 7, 2023 | Q2 2023 | -$0.28Est: -$0.47 | +40.4% | $20.8MEst: $19.2M | +8.3% | 10-Q |
| May 9, 2023 | Q1 2023 | -$0.31Est: -$0.53 | +41.5% | $17.5MEst: $16.3M | +7.4% | — |